November 9th, 2026Comparing Treatment Approaches in Second-Line Metastatic ccRCCDuring a live event, Pedro Barata, MD, MSc, and participating oncologists discussed how efficacy, tolerability, and clinical evidence inform subsequent-line treatment selection for metastatic clear cell renal cell carcinoma.Read more